Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL492522

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CC(C)(O)C#CCC1(C2=CC[C@H]3/C(=C/C=C4C[C@@H](O)C[C@H](O)C4)CCC[C@]23C)CC1

Basic Information

ChEMBL ID CHEMBL492522
Phase Preclinical
Structure Type MOL
InChI Key SQQFWFHESZUDGZ-KYJHDPMGSA-N
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

410.6
MW (Da)
4.83
ALogP
3
HBA
3
HBD
60.7
PSA (Ų)
0.46
QED
0
Ro5 Violations
3
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C27H38O3
MW 410.60
Aromatic Rings 0
Heavy Atoms 30
NP-Likeness 1.66

Activity Summary

IC50 2 meas. best 10.6

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
PBMC
CHEMBL613107
IC50 10.6 10.6 0.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
PBMC IC50 = 0.025 nM 10.6 Inhibition of LPS-induced TNFalpha production in human PBMC after 24 hrs by ELIS... 19309155

Literature References

PubMed DOI Target Context # Activities
19309155 10.1021/jm801365a PBMC 2

Data from ChEMBL 36 via Core Engine